Immutep Ltd has released a press release.
Immutep reports improving results from INSIGHT-004 trial
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immutep
- IMM & Monash Uni receive funding grant for LAG-3 Research
- Appendix 4E & 2020 Full Year Statutory Accounts
- Recruitment of stage 1 of part B in TACTI-002 study complete
- Immutep granted US patent for eftilagimod alpha
- US patent granted for IMP701 antibody
Later from Immutep
- Immutep granted European patent for IMP761
- COVID-19 phase 2 investigator initiated trial commences
- 2020 AGM Presentation
- Immutep enters into a Licence & Collaboration with LabCorp
- Immutep Announces Australian Patent Grant for IMP701
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep